Jun 05, 2026
BOZEMAN, Mont. --(BUSINESS WIRE)--Jun. 5, 2026-- Vision Aerial today announced that Mobix Labs, Inc. (Nasdaq: MOBX) has signed a binding Letter of Intent to acquire Vision Aerial, a U.S.-based builder of American-made drones for government, public safety, energy, infrastructure and industrial
Jun 04, 2026
IRVINE, Calif. --(BUSINESS WIRE)--Jun. 4, 2026-- Mobix Labs, Inc. (Nasdaq: MOBX) today announced that it has signed a binding Letter of Intent to acquire Vision Aerial, Inc., a Montana -based manufacturer of American-built drones trusted in national security, government, energy, public safety and
May 19, 2026
IRVINE, Calif. --(BUSINESS WIRE)--May 19, 2026-- Mobix Labs, Inc. (Nasdaq: MOBX) today announced that it has fully extinguished its $4 million convertible note with Leviston Resources, LLC. All shares issued upon conversion have been registered and resold by Leviston pursuant to the Company's
May 14, 2026
IRVINE, Calif. --(BUSINESS WIRE)--May 14, 2026-- Mobix Labs (Nasdaq: MOBX) today announced a non-binding Letter of Intent to acquire Special Project Delivery LLC ("SPD"), a U.S. company building sovereign supply chains for rare earth elements, critical minerals, and energy storage.
May 12, 2026
IRVINE, Calif. --(BUSINESS WIRE)--May 12, 2026-- Mobix Labs, Inc. (Nasdaq: MOBX) today announced an additional aerospace order for Mobix Labs technology supporting a certified onboard aircraft system for Boeing 737NG commercial aircraft. More than 5,000 Boeing 737NG aircraft operate across global
May 12, 2026
IRVINE, Calif. --(BUSINESS WIRE)--May 12, 2026-- Mobix Labs, Inc. (NASDAQ: MOBX), a provider of advanced connectivity and high-reliability technology solutions for aerospace, defense, and mission-critical applications, today announced a new aerospace product order from a returning customer,
Apr 22, 2026
IRVINE, Calif. --(BUSINESS WIRE)--Apr. 22, 2026-- Mobix Labs, Inc. (NASDAQ: MOBX) announced it has regained compliance with Nasdaq’s $1.00 minimum bid price requirement, resolving its prior listing deficiency. Nasdaq confirmed compliance after the Company’s stock traded at or above $1.00 for the
Displaying 1 - 10 of 32